These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of clarithromycin-sensitive and clarithromycin-resistant Mycobacterium avium strains isolated from AIDS patients during therapy regimens including clarithromycin. Matsiota-Bernard P; Zinzendorf N; Onody C; Guenounou M J Infect; 2000 Jan; 40(1):49-54. PubMed ID: 10762111 [TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind trial comparing azithromycin and clarithromycin in the treatment of disseminated Mycobacterium avium infection in patients with human immunodeficiency virus. Dunne M; Fessel J; Kumar P; Dickenson G; Keiser P; Boulos M; Mogyros M; White AC; Cahn P; O'Connor M; Lewi D; Green S; Tilles J; Hicks C; Bissett J; Schneider MM; Benner R Clin Infect Dis; 2000 Nov; 31(5):1245-52. PubMed ID: 11073759 [TBL] [Abstract][Full Text] [Related]
4. Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group. Shafran SD; Talbot JA; Chomyc S; Davison E; Singer J; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG Clin Infect Dis; 1998 Dec; 27(6):1401-5. PubMed ID: 9868650 [TBL] [Abstract][Full Text] [Related]
5. A Rapid Screening Assay for Clarithromycin-Resistant Mycobacterium avium Complex Using Melting Curve Analysis with Nonfluorescent Labeled Probes. Aoki A; Jinno H; Ogawa K; Nakagawa T; Inagaki T; Wajima T; Okamoto Y; Uchiya KI Microbiol Spectr; 2023 Feb; 11(1):e0432622. PubMed ID: 36622171 [TBL] [Abstract][Full Text] [Related]
6. Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS. Cohn DL Drugs; 1997; 54 Suppl 2():8-15; discussion 28-9. PubMed ID: 9358195 [TBL] [Abstract][Full Text] [Related]
7. Mycobacterium avium strains resistant to clarithromycin and azithromycin. Heifets L; Mor N; Vanderkolk J Antimicrob Agents Chemother; 1993 Nov; 37(11):2364-70. PubMed ID: 8031351 [TBL] [Abstract][Full Text] [Related]
8. Prevention of the selection of clarithromycin-resistant Mycobacterium avium-intracellulare complex. Grosset J; Ji B Drugs; 1997; 54 Suppl 2():23-7; discussion 28-9. PubMed ID: 9358197 [TBL] [Abstract][Full Text] [Related]
9. Randomized, open-label trial of azithromycin plus ethambutol vs. clarithromycin plus ethambutol as therapy for Mycobacterium avium complex bacteremia in patients with human immunodeficiency virus infection. Veterans Affairs HIV Research Consortium. Ward TT; Rimland D; Kauffman C; Huycke M; Evans TG; Heifets L Clin Infect Dis; 1998 Nov; 27(5):1278-85. PubMed ID: 9827282 [TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of treatment of Mycobacterium avium complex bacteremia using a clarithromycin-containing regimen. Burman WJ; Stone BL; Rietmeijer CA; Maslow J; Cohn DL; Reves RR AIDS; 1998 Jul; 12(11):1309-15. PubMed ID: 9708410 [TBL] [Abstract][Full Text] [Related]
13. Minimum inhibitory concentrations of azithromycin in clinical isolates of Uwamino Y; Aoki W; Inose R; Kamoshita Y; Mikita K; Namkoong H; Nishimura T; Matsushita H; Hasegawa N Microbiol Spectr; 2024 Jun; 12(6):e0021824. PubMed ID: 38687080 [TBL] [Abstract][Full Text] [Related]
14. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial. Dautzenberg B; Truffot C; Legris S; Meyohas MC; Berlie HC; Mercat A; Chevret S; Grosset J Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):564-9. PubMed ID: 1832527 [TBL] [Abstract][Full Text] [Related]
15. Current strategies for the prevention and treatment of disseminated Mycobacterium avium complex infection in patients with AIDS. Wright J Pharmacotherapy; 1998; 18(4):738-47. PubMed ID: 9692648 [TBL] [Abstract][Full Text] [Related]
16. Acquired resistance in Mycobacterium avium complex strains isolated from AIDS patients and beige mice during treatment with clarithromycin. Doucet-Populaire F; Truffot-Pernot C; Grosset J; Jarlier V J Antimicrob Chemother; 1995 Jul; 36(1):129-36. PubMed ID: 8537260 [TBL] [Abstract][Full Text] [Related]
17. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team. Benson CA; Williams PL; Cohn DL; Becker S; Hojczyk P; Nevin T; Korvick JA; Heifets L; Child CC; Lederman MM; Reichman RC; Powderly WG; Notario GF; Wynne BA; Hafner R J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562 [TBL] [Abstract][Full Text] [Related]
18. Mycobacterium avium disease: progress at last. Bates JH Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1737-8. PubMed ID: 8665029 [No Abstract] [Full Text] [Related]
19. Antimycobacterial synergism of clarithromycin and rifabutin. Ghebremichael S; Svenson SB; Källenius G; Hoffner SE Scand J Infect Dis; 1996; 28(4):387-90. PubMed ID: 8893404 [TBL] [Abstract][Full Text] [Related]
20. Presence of macrolide resistance in respiratory flora of HIV-Infected patients receiving either clarithromycin or azithromycin for Mycobacterium avium complex prophylaxis. Aberg JA; Wong MK; Flamm R; Notario GF; Jacobson MA HIV Clin Trials; 2001; 2(6):453-9. PubMed ID: 11742432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]